SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst intense community debate after pulling its compounded weight-loss pill following regulatory pressure, coinciding with significant buzz around its Super Bowl commercial. Investors are sharply divided, with bulls anticipating a rebound from reduced legal risk, while bears predict further downside due to perceived management missteps and a hit to the company's growth narrative.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending due to record Super Bowl betting volume and its ongoing expansion into prediction markets, sparking community debate over immediate revenue opportunities versus competitive pressures and the evolving regulatory landscape surrounding these platforms.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is actively discussed as political and cultural commentary intensifies around the Super Bowl halftime show, prompting widespread debate on "anti-American" themes and "woke" culture, while concurrently fueling speculation about Donald Trump's past associations, particularly regarding the Epstein files.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as community sentiment soars after Hims & Hers pulled its compounded weight-loss pill following regulatory scrutiny and NVO's legal threats, reinforcing the competitive advantage of approved GLP-1 therapies. Many anticipate a significant boost to NVO's market share for its Wegovy pill, with additional buzz surrounding its Super Bowl commercial amplifying discussions on potential sales impact.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending ahead of its Q4 earnings report on Monday, with the community highly anticipating a strong beat and solid 2026 guidance for its AI-powered credit platform. Investors are keenly watching for a potential short squeeze, believing the stock remains significantly undervalued despite recent market volatility and fresh funding agreements.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending amid a broader software sector sell-off driven by fears that AI will disrupt established business models, despite the company securing a significant $5.6 billion U.S. Army contract and actively integrating AI through initiatives like Agentforce. The community is sharply divided between those viewing the current dip as a generational buying opportunity and those concerned about a lasting valuation reset for enterprise SaaS.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending after announcing a $250 million financing amendment extending its capital runway through 2028, triggering widespread community speculation for a potential short squeeze, though some caution against its history of volatility and concerns over dilution.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is garnering significant buzz following its impactful Super Bowl commercial featuring Christina Applegate, which the community expects to drive Briumvi's patient adoption and sales amidst positive preliminary financial results and ongoing discussions about its strong market position and buyout potential.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is seeing intense community discussion amid technical glitches preventing users from closing Super Bowl prediction market contracts, all while the stock's price remains closely tied to cryptocurrency volatility ahead of its earnings report.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending following its announcement of an expected first-ever adjusted quarterly operating profit and reaching 100 million battery swaps. This news has sparked a fervent debate among investors regarding its true valuation, with bulls anticipating a significant re-rating while bears caution against a temporary rally amid ongoing dilution concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Moderate Buy" from Brokerages

Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven analysts that are covering the firm, Marketbeat Ratings reports...

Principal Financial Group Inc. Cuts Holdings in Collegium Pharmaceutical, Inc. $COLL

Principal Financial Group Inc. lowered its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 10.7% during the third quarter, according to its most recent 13F filing with the...

Emerald Mutual Fund Advisers Trust Sells 154,973 Shares of Collegium Pharmaceutical, Inc. $COLL

Emerald Mutual Fund Advisers Trust trimmed its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 28.1% in the third quarter, according to its most recent disclosure...

Collegium Pharmaceutical, Inc. $COLL Shares Sold by Emerald Advisers LLC

Emerald Advisers LLC reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 23.6% during the 3rd quarter, according to the company in its most recent filing with...

Eastern Bank Buys 45,508 Shares of Collegium Pharmaceutical, Inc. $COLL

Eastern Bank lifted its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 487.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities...

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Corcept (CORT) Surges 9.8%: Is This an Indication of Further Gains?

Corcept (CORT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

MD is positioned for growth on stronger collections, payer mix and acquisitions, as shares jump 55.2% in six months, beating the industry's 6.7% gain.

Why You Should Add Encompass Health to Your Portfolio Now

EHC's expanding rehabilitation hospital network, strong cash flow and growing patient volumes reinforce its market position.

Here's Why You Should Retain Community Health Stock for Now

CYH shows improving occupancy, targeted acquisitions and divestitures and a rising cash flow outlook, making the hospital operator worth holding for now.

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Collegium Pharmaceutical Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$47.61
Prev Close	$46.92
Open	$47.48
Dividend Yield	0.00%
50-Day Moving Average	$47.34
Beta	0.59
Avg. Volume	517,759.55
PE Ratio	29.63

52-Week High	$50.79
52-Week Low	$23.23
Market Capitalization	$1.55B
EPS (Annual)	$1.86
Price to Book	5.47
Revenue Per Employee	$1.77M
Enterprise Value/EBITDA	N/A

COLL
Collegium Pharmaceutical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest COLL News

COLLCollegium Pharmaceutical Inc